Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,389.40
6.10 (0.44%)
Medium VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.12L Cr
LARGE CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
28.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,165.7+19.2%
52W High₹1,673-17.0%
Current Price
₹1,389.40
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,111.52
Upper Circuit₹1,667.28
Reference Price
₹1,389.40
Investment Checklist
Head and Shoulders on 1W (BREAKOUT CONFIRMED) — target ₹1297.6
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹1348.8
10/20 Bearish Cross detected 3 day(s) ago
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
44%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
1382.05
EMA50
1351.64
EMA200
1402.15
Price Action
CONSOLIDATION
NEUTRAL
Higher Highs3
Higher Lows5
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹1469.50
₹1533.71
₹1592.90
₹1673.00
Support (Below)
₹1381.30
₹1354.65
₹1312.30
₹1283.03
₹1257.00
Volume Analysis
TrendDECREASING
Change-42.40%
Unusual VolumeNo
Recent MA Crossovers
10/20 Bearish Cross
3 days ago
SELL
Stop Loss Levels
Fixed Risk
1% Risk₹1375.51
3% Risk₹1347.72
5% Risk₹1319.93
7% Risk (Custom)
₹1292.14Technical Levels
1x ATR (Volatility)₹1362.17
2x ATR (Swing)₹1334.94
3x ATR (Trend)₹1307.71
Immediate Support₹1381.30
Moving Averages
EMA 9 (Short-term)₹1387.21
EMA 20 (Medium-term)₹1382.05
EMA 50 (Trend)₹1351.64
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹6,961.6 Cr | ₹6,597.7 Cr | ₹6,837 Cr | ₹6,963 Cr |
| Net Profit | ₹1,570.5 Cr | ₹1,221.8 Cr | ₹1,297.6 Cr | ₹675.8 Cr |
| EPS | ₹19.45 | — | ₹16.07 | ₹8.37 |
| Operating Profit | ₹2,210.5 Cr | ₹1,697.6 Cr | ₹2,036.7 Cr | ₹1,185.5 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
| BIOCON | Biocon Limited | ₹419.00 | +0.73% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 05 Jun 2026 | Dividend - Rs 13 Per Share | DIVIDEND |
| 27 Jun 2025 | Dividend - Rs 13 Per Share/Special Dividend - Rs 3 Per Share | SPECIAL_DIVIDEND |
| 02 Aug 2024 | Dividend - Rs 13 Per Share | DIVIDEND |
| 21 Jul 2023 | Dividend - Rs 8.50 Per Share | DIVIDEND |
| 08 Aug 2022 | Dividend - Rs 5 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for CIPLA
View All
positive
ET Markets - Stocks 1d ago
Cipla Share Price Live Updates: Cipla's Monthly Return Analysis
CIPLAHealthcare
neutral
Business Standard - Markets 1d ago
Stocks to Watch today: Vedanta, Cipla, Dabur, Vi, Oil India, CDSL and more
Stocks to watch today: Vedanta, Cipla, Dabur, Vi, Oil India, CDSL, Ratnaveer Precision, NLC India, Sagility among others will in focus today.
CDSLCIPLADABURFOCUSNLCINDIAOILPRECISIONRATNAVEERSAGILITYVEDLAutomobile and Auto ComponentsCapital Goods
neutral
CNBC TV18 - Markets 2d ago
Cipla's Goa plant gets VAI status from USFDA after April inspection; Here's what it means
Cipla said the USFDA has classified its April inspection of the company's Goa manufacturing facility as Voluntary Action Indicated (VAI), a status under which observations are expected to be addressed voluntarily without regulatory action.
CIPLAHealthcare